We've planted the flag of expertise.

In funding more than $200 million in CF research since 1960, we’ve had a hand in nearly every major CF discovery. It was Canadian researchers who: 

Discovered the gene responsible for CF, opening the door to targeting the cause of the disease rather than its symptoms. 

Developed and demonstrated the clinical benefits of the revolutionary high-fat diet adopted globally to improve nutrition. 

Purified the CFTR protein, improving understanding of its structure and function, and leading to development of KALYDECO™. 

Developed the “Toronto Protocol” that has now been broadly adopted to repair donor lungs and improve transplant outcomes. 

Identified a novel approach to treating bacterial infections that was adopted as a best practice in clinical care.